Compound useful as reversible inhibitors of cysteine proteases
Disclosed are novel cathepsin S, K, F, L and B reversible inhibitory compounds of the formulas (I), (II), (Ia) and (Ib) further defined herein. The compounds are useful for treating autoimmune diseases. Also disclosed are processes for making such novel compounds. 
Boehringer Ingelheim Pharmaceuticals, Inc.
C C A C C C A C A A C C C A C A A A C C A A C A C C C C C
C07D C07D A61P C07D C07D C07D A61P C07D A61P A61P C07D C07D C07D A61P C07D A61P A61P A61P C07D C07D A61P A61P C07D A61P C07D C07D C07D C04B C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Leah L. Erick Richard Roush Sanxing David S. Yancey David Weimin Tina Marie Denice Mary Eugene R. Michel Jose
Frye Young Sun Thomson Ward Liu Morwick Spero Hickey Emmanuel